Evidence map›Paper›PMID 28837558›Full record

ArticlePloS one2017

The prevalence and incidence of active syphilis in women in Morocco, 1995-2016: Model-based estimation and implications for STI surveillance.

Aziza Bennani, Amina El-Kettani, Amina Hançali, Houssine El-Rhilani, Kamal Alami, Mohamed Youbi, Jane Rowley, Laith Abu-Raddad, Alex Smolak, Melanie Taylor and 3 more

Open access · goldAbstract readHistorical Article
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. An Update on the Global Epidemiology of Syphilis.Current epidemiology reports · 2018
    Article
  5. Article
  6. Prevalence and incidence estimates for syphilis, chlamydia, gonorrhea, and congenital syphilis in Colombia, 1995-2016.Revista panamericana de salud publica = Pan American journal of public health · 2018
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

Aziza BennaniMinistry of Health, Directorate of Epidemiology and Disease Control, Rabat, Morocco.
Amina El-KettaniMinistry of Health, Directorate of Epidemiology and Disease Control, Rabat, Morocco.
Amina HançaliSTIs Laboratory, Department of Bacteriology, National Institute of Hygiene, Rabat, Morocco.
Houssine El-RhilaniUNAIDS Morocco country office, Rabat, Morocco.
Kamal AlamiUNAIDS Morocco country office, Rabat, Morocco.
Mohamed YoubiMinistry of Health, Directorate of Epidemiology and Disease Control, Rabat, Morocco.
Jane RowleyLondon, United Kingdom.
Laith Abu-RaddadWeill Cornell Medical College - Qatar, Cornell University, Doha, Qatar.
Alex SmolakWeill Cornell Medical College - Qatar, Cornell University, Doha, Qatar.
Melanie TaylorWorld Health Organization, Dept. of Reproductive Health and Research, Geneva, Switzerland.
Guy MahianéAvenir Health, Glastonbury, Connecticut, United States of America.
John StoverAvenir Health, Glastonbury, Connecticut, United States of America.
Eline L KorenrompAvenir Health, Glastonbury, Connecticut, United States of America.ORCID http://orcid.org/0000-0002-5301-8461
Avenir Health · USMinistère de la Santé · MAWeill Cornell Medical College in Qatar · QACenters for Disease Control and Prevention · USInstitut National d'Hygiène du Maroc · MA

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundEvolving health priorities and resource constraints mean that countries require data on trends in sexually transmitted infections (STI) burden, to inform program planning and resource allocation. We applied the Spectrum STI estimation tool to estimate the prevalence and incidence of active syphilis in adult women in Morocco over 1995 to 2016. The results from the analysis are being used to inform Morocco's national HIV/STI strategy, target setting and program evaluation.

methodsSyphilis prevalence levels and trends were fitted through logistic regression to data from surveys in antenatal clinics, women attending family planning clinics and other general adult populations, as available post-1995. Prevalence data were adjusted for diagnostic test performance, and for the contribution of higher-risk populations not sampled in surveys. Incidence was inferred from prevalence by adjusting for the average duration of infection with active syphilis.

resultsIn 2016, active syphilis prevalence was estimated to be 0.56% in women 15 to 49 years of age (95% confidence interval, CI: 0.3%-1.0%), and around 21,675 (10,612-37,198) new syphilis infections have occurred. The analysis shows a steady decline in prevalence from 1995, when the prevalence was estimated to be 1.8% (1.0-3.5%). The decline was consistent with decreasing prevalences observed in TB patients, fishermen and prisoners followed over 2000-2012 through sentinel surveillance, and with a decline since 2003 in national HIV incidence estimated earlier through independent modelling.

conclusionsPeriodic population-based surveys allowed Morocco to estimate syphilis prevalence and incidence trends. This first-ever undertaking engaged and focused national stakeholders, and confirmed the still considerable syphilis burden. The latest survey was done in 2012 and so the trends are relatively uncertain after 2012. From 2017 Morocco plans to implement a system to record data from routine antenatal programmatic screening, which should help update and re-calibrate next trend estimations.

Indexed as

Models, TheoreticalPopulation SurveillanceFemaleHistory, 20th CenturyHistory, 21st CenturyHumansIncidenceMoroccoPrevalenceSyphilis

Identifiers

PMID28837558
PMCPMC5570350
OpenAlexW2743066945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.